Penserra Capital Management LLC Bristol Myers Squibb CO Transaction History

Penserra Capital Management LLC

$7.96 Billion
Q1 2024

A detailed history of Penserra Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Penserra Capital Management LLC holds 3,923 shares of BMY stock, worth $158,685. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,923

Previous 10,791 63.65%

Holding current value

$158,685

Previous $552,000 61.78%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $329,526 - $373,619	-6,868 Reduced 63.65%	3,923 $211,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $79,458 - $94,816	-1,639 Reduced 13.19%	10,791 $552,000
Q3 2023 Nov 15, 2023	SELL	$57.89 - $64.73 $118,558 - $132,567	-2,048 Reduced 14.15%	12,430 $720,000
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $842,437 - $935,395	13,223 Added 1053.63%	14,478 $925,000
Q1 2023 Apr 24, 2023	SELL	$65.71 - $74.53 $2.94 Million - $3.34 Million	-44,757 Reduced 97.27%	1,255 $86,000

Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $3.01 Million - $3.56 Million	43,921 Added 2100.48%	46,012 $3.31 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $5,567 - $3.29 Million	-42,830 Reduced 95.35%	2,091 $148,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $3.08 Million - $3.4 Million	42,452 Added 1719.4%	44,921 $3.46 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $115,643 - $138,667	1,881 Added 319.9%	2,469 $179,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $3,539 - $4,126	66 Added 12.64%	588 $36,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $6,922 - $8,109	117 Added 28.89%	522 $30,000
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $25,073 - $27,305	405 New	405 $27,000
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $965,165 - $1.09 Million	-16,265 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $26,791 - $30,359	-464 Reduced 2.77%	16,265 $1.01 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $3.19 Million - $3.54 Million	-55,596 Reduced 76.87%	16,729 $1.01 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $3.69 Million - $4.32 Million	67,355 Added 1355.23%	72,325 $4.25 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $160,451 - $233,172	3,458 Added 228.7%	4,970 $303,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $74,405 - $97,055	1,512 New	1,512 $96,000
Q4 2018 Feb 06, 2019	SELL	$48.76 - $63.23 $260,183 - $337,395	-5,336 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$55.19 - $62.25 $41,613 - $46,936	754 Added 16.46%	5,336 $331,000
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $24,153 - $30,104	478 Added 11.65%	4,582 $253,000
Q1 2018 May 08, 2018	BUY	$59.92 - $68.98 $19,414 - $22,349	324 Added 8.57%	4,104 $259,000
Q4 2017 Feb 07, 2018	BUY	$59.94 - $65.35 $35,604 - $38,817	594 Added 18.64%	3,780 $231,000
Q3 2017 Oct 26, 2017	BUY	$55.23 - $63.74 $20,876 - $24,093	378 Added 13.46%	3,186 $205,000
Q2 2017 Aug 21, 2017	BUY	N/A	2,808	2,808 $156,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Account

Penserra Capital Management LLC Bristol Myers Squibb CO Transaction History